Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
podcast
Tags
life sciences
national blog main
boston blog main
boston
boston top stories
alnylam pharmaceuticals
biotech
clinical trials
drugs
rna interference
national top stories
new york blog main
new york top stories
san francisco blog main
science
deals
fda
medicine
patisiran
san diego blog main
san diego top stories
san francisco top stories
akcea therapeutics
aminolevulinic acid
archive
barry greene
biology
boehringer ingelheim
cancer
cells
dan ollendorf
eli lilly
extreme
givosiran
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
mrna
onpattro
What
rna
20
×
medicine
new
drug
alnylam
interference
medicines
researchers
rnai
fda
gene
pharmaceuticals
second
ago
announced
based
companies
company
deal
discovery
evidence
help
molecules
mrna
pharma
science
time
way
approval
betting
cancer
data
development
diseases
dna
effective
genetic
historic
human
launch
Language
unset
Current search:
rna
×
@thefastmode.com
2 months ago
Cognizant to Support Alnylam's IT Transformation and Accelerate Medicine Delivery
@theverge.com
8 months ago
Google DeepMind’s new AI can model DNA, RNA, and ‘all life’s molecules’
@slashgear.com
2 years ago
Moderna’s mRNA HIV vaccine trial kicks off with first round of doses
@techcrunch.com
3 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@slashgear.com
3 years ago
Scientists discover that RNA segments can be written back into DNA
@wired.com
4 years ago
Squids' Gene-Editing Superpowers May Unlock Human Cures
@xconomy.com
5 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
6 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
6 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
6 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@extremetech.com
8 years ago
Scientists find abandoned drug effective against two human viruses
@extremetech.com
9 years ago
Triple-helix RNA cancer treatment from MIT shows major promise
@WIRED
9 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.
@theverge.com
9 years ago
Sequencing the RNA of sperm may better diagnose a man's infertility